+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Molecule Type and MicroRNA , Application, Route of Administration, and End User and Country

  • ID: 5204965
  • Report
  • October 2020
  • Region: Asia Pacific
  • 133 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Benitec Biopharma
  • GlaxoSmithKline plc
  • MORE
Small Interfering RNAs (siRNA) Segment Held Largest Share of APAC RNAi Therapeutics Market in 2019

According to the new market research study on “Asia Pacific RNAi Therapeutics Market to 2027 - Regional Analysis and Forecast - by Molecule Type, Route of Administration, Application, and End User” the Asia Pacific RNAi therapeutics market is expected to reach US$218.64 million by 2027 from US$107.63 million in 2019, it is estimated to grow at a CAGR of 9.3% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific RNAi therapeutics market and the factors driving the market growth along with those hindering it.

In 2019, the small interfering RNAs (siRNA) segment accounted for higher share of the market. Growth of this segment is attributed to increasing preference for small interfering RNAs for drug development and growing number of research partnerships. The microRNA (miRNA) segment is expected to register higher CAGR in the RNAi therapeutics market during the forecast period.

The growth of the Asia Pacific RNAi therapeutics market is mainly attributed to growing prevalence of chronic conditions and rising investments for development of RNAi therapeutics. Additionally, increasing awareness about RNAi therapies and their benefits are anticipated to boost the research and innovations of RNAi therapeutics in the region, which would eventually drive the market growth. However, the high cost of RNAi therapy development is the major factor hindering the market growth in Asia Pacific.

Benitec Biopharma; Olix Pharmaceuticals, Inc; GlaxoSmithKline plc; Alnylam Pharmaceuticals, Inc; and Arrowhead Pharmaceuticals, Inc are among the leading companies operating in the Asia Pacific RNAi therapeutics market.

The report segments the Asia Pacific RNAi therapeutics market as follows:

Asia Pacific RNAi Therapeutics Market - by Molecule Type
  • Small Interfering RNAs (siRNA)
  • MicroRNA (miRNA)
Asia Pacific RNAi Therapeutics Market - by Route of Administration
  • Pulmonary Delivery
  • Intravenous Injections
  • Intradermal Injections
  • Intraperitoneal Injections
  • Others
Asia Pacific RNAi Therapeutics Market - by Application
  • Oncology
  • Cardiovascular
  • Respiratory Disorders
  • Renal Diseases
  • Genetic Disorders
  • Neurodegenerative Disorders
  • Infectious Diseases
  • Others
Asia Pacific RNAi Therapeutics Market - by End User
  • Research and Academic Laboratories
  • Hospitals
  • Diagnostic Laboratories
Asia Pacific RNAi Therapeutics Market - by Country
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
Reasons to Buy
  • It provides an understanding of the Asia Pacific RNAi therapeutics market landscape and identifies RNAi therapeutics market segments that are most likely to guarantee a strong returnIt guides to
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific RNAi therapeutics market
  • It helps efficiently plan merger and acquisition and partnership deals in the RNAi therapeutics market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of various segments pertaining to the Asia Pacific RNAi therapeutics market.
  • It provides revenue forecast of the market based on various segments for the period from 2019 to 2027
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Benitec Biopharma
  • GlaxoSmithKline plc
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific RNAi Therapeutics Market - By Molecule Type
1.3.2 Asia Pacific RNAi Therapeutics Market - By Application
1.3.3 Asia Pacific RNAi Therapeutics Market - By Route of Administration
1.3.4 Asia Pacific RNAi Therapeutics Market- By End User
1.3.5 Asia Pacific RNAi Therapeutics Market - By Country

2. Asia Pacific RNAi Therapeutics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific RNAi Therapeutics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 RNAi therapeutics Market - Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific RNAi Therapeutics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Investments in RNAi Therapies
5.1.2 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost for RNAi Therapy Development
5.3 Market Opportunities
5.3.1 Significant Number of Pipeline Candidates for Strategic Alliances
5.4 Future Trends
5.4.1 Rising Emphasis on RNA Technologies
5.5 Impact analysis

6. RNAi Therapeutics Market - Asia Pacific Analysis
6.1 Asia Pacific RNAi Therapeutics Market Revenue Forecasts and Analysis

7. Asia Pacific RNAi Therapeutics Market Analysis and Forecasts To 2027 - By Molecule Type
7.1 Overview
7.2 Asia Pacific RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)
7.2.1 Asia Pacific RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)
7.3 Small Interfering RNAs (siRNA)
7.3.1 Overview
7.3.2 Asia Pacific Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)
7.4 MicroRNA (miRNA)
7.4.1 Overview
7.4.2 Asia Pacific MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

8. Asia Pacific RNAi therapeutics Market Analysis and Forecasts To 2027 - By Application
8.1 Overview
8.2 Asia Pacific RNAi therapeutics Market, By Application 2019 & 2027 (%)
8.2.1 Asia Pacific RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Genetic Disorders
8.3.1 Overview
8.3.2 Asia Pacific Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Oncology
8.4.1 Overview
8.4.2 Asia Pacific Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Neurodegenerative Disorders
8.5.1 Overview
8.5.2 Asia Pacific Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Cardiovascular Disorders
8.6.1 Overview
8.6.2 Asia Pacific Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Asia Pacific Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Infectious Diseases
8.8.1 Overview
8.8.2 Asia Pacific Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Renal Diseases
8.9.1 Overview
8.9.2 Asia Pacific Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 Other Disorders
8.10.1 Overview
8.10.2 Asia Pacific Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

9. Asia Pacific RNAi therapeutics Market Analysis and Forecasts To 2027 - By Route of Administration
9.1 Overview
9.2 Asia Pacific RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)
9.2.1 Asia Pacific RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)
9.3 Intradermal Injections
9.3.1 Overview
9.3.2 Asia Pacific Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Pulmonary Delivery
9.4.1 Overview
9.4.2 Asia Pacific Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Intravenous Injections
9.5.1 Overview
9.5.2 Asia Pacific Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Intraperitoneal Injections
9.6.1 Overview
9.6.2 Asia Pacific Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Other Route of Administrations
9.7.1 Overview
9.7.2 Asia Pacific Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

10. Asia Pacific RNAi Therapeutics Market Analysis - By End-User
10.1 Overview
10.2 Asia Pacific RNAi Therapeutics Market, By End-User 2019-2027 (%)
10.2.1 Asia Pacific RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 Asia Pacific Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Research and Academic Laboratories
10.4.1 Overview
10.4.2 Asia Pacific Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Hospitals
10.5.1 Overview
10.5.2 Asia Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

11. RNAi therapeutics Market Revenue and Forecasts To 2027 - Geographical Analysis
11.1 Asia Pacific: RNAi Therapeutics Market
11.1.1 Overview
11.1.2 Asia Pacific: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Asia Pacific: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.4 Asia Pacific: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.5 Asia Pacific: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.6 Asia Pacific: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.7 Asia Pacific: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
11.1.8 China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 China: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.8.3 China: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.8.4 China RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.8.5 China RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.9 Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Japan: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.9.3 Japan: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.9.4 Japan RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.9.5 Japan RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.10 India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 India: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.10.3 India: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.10.4 India RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.10.5 India RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.11 South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 South Korea: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.11.3 South Korea: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.11.4 South Korea RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.11.5 South Korea RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.12 Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Australia: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.12.3 Australia: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.12.4 Australia RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.12.5 Australia RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)

12. Impact of COVID-19 Pandemic on Asia Pacific RNAi therapeutics Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

13. Company Profiles
13.1 Benitec Biopharma
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Olix Pharmaceuticals, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Alnylam Pharmaceuticals, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Arrowhead Pharmaceuticals, Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

List of Tables
Table 1. Asia Pacific RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)
Table 2. Asia Pacific RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Asia Pacific RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)
Table 4. Asia Pacific RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 5. Asia Pacific RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 7. Asia Pacific RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 8. Asia Pacific RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 9. China RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 10. China RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 11. China RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 12. China RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 13. Japan RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Japan RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Japan RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 16. Japan RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 17. India RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 18. India RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 19. India RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 20. India RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 25. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 26. Australia RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Australia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 28. Australia RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 29. Australia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 30. Glossary of Terms, RNAi Therapeutics Market

List of Figures
Figure 1. RNAi Therapeutics Market Segmentation
Figure 2. Asia Pacific RNAi Therapeutics Market Overview
Figure 3. Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market
Figure 4. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific RNAi Therapeutics Market - Leading Country Markets (US$ Mn)
Figure 6. RNAi Therapeutics Market - Asia Pacific PEST Analysis
Figure 7. RNAi Therapeutics Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific RNAi Therapeutics Market - Revenue Forecasts and Analysis - 2019-2027
Figure 9. Asia Pacific RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)
Figure 10. Asia Pacific Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific RNAi therapeutics Market, By Application 2019 & 2027 (%)
Figure 13. Asia Pacific Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)
Figure 22. Asia Pacific Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia Pacific Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Asia Pacific RNAi Therapeutics Market, by End-User 2019 & 2027 (%)
Figure 28. Asia Pacific Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Asia Pacific Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Asia Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Asia Pacific: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 32. Asia Pacific RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 33. China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Note: Product cover images may vary from those shown
3 of 3
  • Benitec Biopharma
  • Olix Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Alnylam Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc
Note: Product cover images may vary from those shown
Adroll
adroll